18F-PSMA-1007 Uptake in Pulmonary Lymphangitic Carcinomatosis Metastasis From Prostate Cancer. (July 2021)

• Record Type: Journal Article
• Authors: Liu, Bo-Le; Hong, Jun-Jie; Tang, Kun; Lin, Jie; Zheng, Xiang-Wu
• Is Part Of: Clinical nuclear medicine. Volume 46:Number 7(2021)
• Publication Date: 2021-07
• Subjects: 18F-PSMA-1007 -- PET/CT -- prostate cancer; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000003582
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract : Abstract: A 55-year-old man with cough, bone pain, and cervical lymphadenopathy underwent both 18 F-FDG and 18 F-PSMA-1007 PET/CT scans with clinical suspicion of malignant disease. Compared with 18 F-FDG PET/CT, 18 F-PSMA PET/CT showed intense tracer uptake in the prostate gland, lungs, osteogenic lesions, and multiple lymph nodes. Interestingly, we also found the high tracer concentration of pulmonary lymphangitic carcinomatosis, a very rare form of prostate cancer metastasis to the lung, on 18 F-PSMA-1007 PET/CT images.